Probability and Predictors of the Cannabis Gateway Effect: a National Study

Overview

Journal Int J Drug Policy

Publisher Elsevier

Specialties Psychiatry
Public Health

Date 2014 Aug 30

PMID 25168081

Citations 57

Authors

Roberto Secades-Villa

Olaya Garcia-Rodriguez

Chelsea J Jin

Shuai Wang

Carlos Blanco

Affiliations

Soon will be listed here.

Abstract

Background: While several studies have shown a high association between cannabis use and use of other illicit drugs, the predictors of progression from cannabis to other illicit drugs remain largely unknown. This study aims to estimate the cumulative probability of progression to illicit drug use among individuals with lifetime history of cannabis use, and to identify predictors of progression from cannabis use to other illicit drugs use.

Methods: Analyses were conducted on the sub-sample of participants in Wave 1 of the National Epidemiological Survey on Alcohol and Related Conditions (NESARC) who started cannabis use before using any other drug (n=6624). Estimated projections of the cumulative probability of progression from cannabis use to use of any other illegal drug use in the general population were obtained by the standard actuarial method. Univariate and multivariable survival analyses with time-varying covariates were implemented to identify predictors of progression to any drug use.

Results: Lifetime cumulative probability estimates indicated that 44.7% of individuals with lifetime cannabis use progressed to other illicit drug use at some time in their lives. Several sociodemographic characteristics, internalizing and externalizing psychiatric disorders and indicators of substance use severity predicted progression from cannabis use to other illicit drugs use.

Conclusion: A large proportion of individuals who use cannabis go on to use other illegal drugs. The increased risk of progression from cannabis use to other illicit drugs use among individuals with mental disorders underscores the importance of considering the benefits and adverse effects of changes in cannabis regulations and of developing prevention and treatment strategies directed at curtailing cannabis use in these populations.

Citing Articles

The relationship between cannabis and cardiovascular disease: clearing the haze.

Chandy M, Jimenez-Tellez N, Wu J Nat Rev Cardiol. 2025; .

PMID: 39849111 DOI: 10.1038/s41569-025-01121-6.

Examining the Potential Impact of Recreational Cannabis Legalization on Individuals Receiving Treatment for Substance Use Disorder: An Interrupted Time Series Study in Guelph, Ontario, Canada.

Britton E, Taisir R, Cooper A, Li Y, Sousa S, Chorny Y Cannabis. 2025; 7(3):74-89.

PMID: 39781557 PMC: 11705041. DOI: 10.26828/cannabis/2024/000260.

Cannabis Vaping Is Associated With Past 30-Day Suicide Attempts and Suicidal Ideation Among Adolescents in a Psychiatric Inpatient Setting.

Thomas S, Thompson E, Maron M, Meisel S, Spirito A, Wolff J JAACAP Open. 2024; 2(4):263-273.

PMID: 39697388 PMC: 11650693. DOI: 10.1016/j.jaacop.2024.03.003.

Chronic exposure to inhaled vaporized cannabis high in Δ-THC suppresses Adderall-induced brain activity.

Ognibene J, Desai R, Kulkarni P, Ferris C Front Pharmacol. 2024; 15:1413812.

PMID: 39494344 PMC: 11528537. DOI: 10.3389/fphar.2024.1413812.

Fear of COVID-19 and illicit drug use during COVID-19 pandemic in Japan: a case-control study.

Nitta K, Naito H, Tabuchi T, Kakiuchi Y PeerJ. 2024; 12:e18137.

PMID: 39346045 PMC: 11439375. DOI: 10.7717/peerj.18137.

References

Kandel D . Marijuana users in young adulthood. Arch Gen Psychiatry. 1984; 41(2):200-9. DOI: 10.1001/archpsyc.1984.01790130096013. View

Compton W, Thomas Y, Stinson F, Grant B . Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007; 64(5):566-76. DOI: 10.1001/archpsyc.64.5.566. View

Regier D, Farmer M, Rae D, Locke B, Keith S, Judd L . Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990; 264(19):2511-8. View

Ours J, Williams J . The effects of cannabis use on physical and mental health. J Health Econ. 2012; 31(4):564-77. DOI: 10.1016/j.jhealeco.2012.04.003. View

Van Gundy K, Rebellon C . A Life-course Perspective on the "Gateway Hypothesis". J Health Soc Behav. 2010; 51(3):244-59. DOI: 10.1177/0022146510378238. View

Martins S, Fenton M, Keyes K, Blanco C, Zhu H, Storr C . Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions. Psychol Med. 2011; 42(6):1261-72. PMC: 3513363. DOI: 10.1017/S0033291711002145. View

Florez-Salamanca L, Secades-Villa R, Hasin D, Cottler L, Wang S, Grant B . Probability and predictors of transition from abuse to dependence on alcohol, cannabis, and cocaine: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Am J Drug Alcohol Abuse. 2013; 39(3):168-79. PMC: 3755735. DOI: 10.3109/00952990.2013.772618. View

van Gastel W, Tempelaar W, Bun C, Schubart C, Kahn R, Plevier C . Cannabis use as an indicator of risk for mental health problems in adolescents: a population-based study at secondary schools. Psychol Med. 2012; 43(9):1849-56. DOI: 10.1017/S0033291712002723. View

Malone P, Lamis D, Masyn K, Northrup T . A Dual-Process Discrete-Time Survival Analysis Model: Application to the Gateway Drug Hypothesis. Multivariate Behav Res. 2010; 45(5):790-805. PMC: 2988450. DOI: 10.1080/00273171.2010.519277. View

10.

Swendsen J, Conway K, Degenhardt L, Dierker L, Glantz M, Jin R . Socio-demographic risk factors for alcohol and drug dependence: the 10-year follow-up of the national comorbidity survey. Addiction. 2009; 104(8):1346-55. PMC: 2794245. DOI: 10.1111/j.1360-0443.2009.02622.x. View

11.

ODonnell J, Clayton R . The stepping-stone hypothesis--marijuana, heroin, and causality. Chem Depend. 1982; 4(3):229-41. View

12.

Primm A, Vasquez M, Mays R, Sammons-Posey D, McKnight-Eily L, Presley-Cantrell L . The role of public health in addressing racial and ethnic disparities in mental health and mental illness. Prev Chronic Dis. 2009; 7(1):A20. PMC: 2811515. View

13.

Kandel D . Does marijuana use cause the use of other drugs?. JAMA. 2003; 289(4):482-3. DOI: 10.1001/jama.289.4.482. View

14.

Makanjuola V, Oladeji B, Gureje O . The gateway hypothesis of substance abuse: an examination of its applicability in the Nigerian general population. Subst Use Misuse. 2010; 45(10):1558-71. DOI: 10.3109/10826081003682081. View

15.

Kandel D, Yamaguchi K, Klein L . Testing the Gateway Hypothesis. Addiction. 2006; 101(4):470-2. DOI: 10.1111/j.1360-0443.2006.01426.x. View

16.

Ruan W, Goldstein R, Chou S, Smith S, Saha T, Pickering R . The alcohol use disorder and associated disabilities interview schedule-IV (AUDADIS-IV): reliability of new psychiatric diagnostic modules and risk factors in a general population sample. Drug Alcohol Depend. 2007; 92(1-3):27-36. PMC: 2246381. DOI: 10.1016/j.drugalcdep.2007.06.001. View

17.

Degenhardt L, Chiu W, Conway K, Dierker L, Glantz M, Kalaydjian A . Does the 'gateway' matter? Associations between the order of drug use initiation and the development of drug dependence in the National Comorbidity Study Replication. Psychol Med. 2008; 39(1):157-67. PMC: 2653272. DOI: 10.1017/S0033291708003425. View

18.

Tarter R, Vanyukov M, Kirisci L, Reynolds M, Clark D . Predictors of marijuana use in adolescents before and after licit drug use: examination of the gateway hypothesis. Am J Psychiatry. 2006; 163(12):2134-40. DOI: 10.1176/ajp.2006.163.12.2134. View

19.

Khan S, Secades-Villa R, Okuda M, Wang S, Perez-Fuentes G, Kerridge B . Gender differences in cannabis use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions. Drug Alcohol Depend. 2012; 130(1-3):101-8. PMC: 3586748. DOI: 10.1016/j.drugalcdep.2012.10.015. View

20.

Pickles A, Pickering K, Simonoff E, Silberg J, Meyer J, Maes H . Genetic "clocks" and "soft" events: a twin model for pubertal development and other recalled sequences of developmental milestones, transitions, or ages at onset. Behav Genet. 1998; 28(4):243-53. DOI: 10.1023/a:1021615228995. View